Kenneth Stein

Kenneth Stein, MD, FACC, FHRS, is currently senior vice president and global chief medical officer, at Boston Scientific. In this role he has oversight for the clinical trials, medical safety and medical affairs functions for Rhythm Management, the Global Clinical Operations (GCO) team and Global Medical Affairs team and is responsible for ensuring a cohesive clinical community of practice across the company. Dr. Stein also represents the clinical voice for our investor audiences.

Ken is a Phi Beta Kappa graduate of Harvard College (in Economics) and earned his MD from New York University School of Medicine. He completed his medical internship and residency at The New York-Presbyterian Hospital/Weill Cornell Medical Center, where he also completed his cardiology and cardiac electrophysiology training.

Previously, he was the company’s senior vice president and chief medical officer, Rhythm Management and Global Health Policy, a role he served in from September 2009 to January 2023. Prior to joining Boston Scientific, Dr. Stein held the position of Associate Director of Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor ofMedicine at Cornell University. Dr. Stein is widely published, having authoring over 150 peer-reviewed scientific publications in the areas of cardiac electrophysiology with special interests in cardiac resynchronization therapy and risk stratification for sudden cardiac arrest.

Since 2013, he has also served on the board of Childrens HeartLink, a registered 501c(3) nonprofit organization that trains and mentors medical teams in underserved parts of the world to diagnose and treat children with heart disease. Founded in 1969, Children’s HeartLink currently supports partner hospitals in Brazil, China, India, Malaysia, Ukraine and Vietnam.